PERSONAL DATA DISTRIBUTION MANAGEMENT SYSTEM AND PERSONAL DATA DISTRIBUTION MANAGEMENT METHOD

    公开(公告)号:US20220374550A1

    公开(公告)日:2022-11-24

    申请号:US17771834

    申请日:2020-10-29

    Inventor: Yasushi YAGI

    Abstract: A personal data distribution management system includes source data management devices, a data distribution management device, and a relay processing device that are separate devices and are connected on a network. The source data management device includes a database that stores personal data on an individual subjected to a measurement with a measuring instrument, and attribute information related to the individual and the measurement, the database storing the personal data and the attribute information as original data associated with real name information on the individual. The data distribution management device fetches original data except for personal data, and creates a data catalog. The relay processing device outputs the data, which is the data except for real name information on individuals and from the database of each source data management device based on the data usage request received from the outside, to a data user terminal. This configuration enables data distribution management that reduces the risk of information leakage of personal data and individual real name information.

    Treatment of pain with serotonin-3 receptor agonist

    公开(公告)号:US11446290B2

    公开(公告)日:2022-09-20

    申请号:US16626062

    申请日:2018-06-27

    Abstract: The present invention provides a drug for preventing or treating chronic pain and a method for preventing or treating chronic pain. A pharmaceutical composition comprising a serotonin-3 receptor agonist such as a compound represented by the following formula (I): [wherein: m is an integer of 1 to 4; and R1 is each independently selected from the group consisting of a hydrogen atom, a halogen atom, a methyl group optionally substituted with 1 to 3 halogen atom(s), a methoxy group optionally substituted with 1 to 3 halogen atom(s), and a methylthio group optionally substituted with 1 to 3 halogen atom(s)] or a pharmaceutically acceptable salt thereof is useful for preventing or treating chronic pain. The above pharmaceutical composition is also useful for preventing or treating acute pain. Further, the present invention provides a method for screening a compound for preventing or treating chronic pain, the method comprising measuring a serotonin-3 receptor agonist activity.

    METHOD FOR PRODUCING VASCULAR ENDOTHELIAL STEM CELL

    公开(公告)号:US20220275343A1

    公开(公告)日:2022-09-01

    申请号:US17638026

    申请日:2020-10-07

    Abstract: The present invention provides a method for artificially producing a vascular endothelial stem cell from a non-vascular endothelial stem cell. The method for producing a vascular endothelial stem cell of the present invention comprises the step of bringing a vascular endothelial cell possessing no stem cell properties into contact with a factor secreted by an organ of a neonatal or juvenile mammal. The step may be a step of (1) transplanting the vascular endothelial cell possessing no stem cell properties into the organ of the neonatal or juvenile mammal, wherein the mammal is a non-human mammal, or (2) culturing the vascular endothelial cell possessing no stem cell properties in a culture system containing the factor secreted by the organ of the neonatal or juvenile mammal.

Patent Agency Ranking